Kim David Lamon

Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY.

Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ.

Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA.

LeukoSite, Inc. develops drugs for treatment of cancer and inflammatory diseases. It produces drugs to block autoimmune and viral diseases associated with malfunctioning leukocytes or white blood cells. The company was founded in 1992 and is located in Cambridge, MA.

Chatterjee Management Co (Chatterjee Management) is a private equity subsidiary of The Chatterjee Group founded in 1989 by Purnandu Chatterjee. The firm is headquartered in New York with additional offices in Bombay, Delhi and Calcutta.

Bacterin International, Inc. manufactured drug delivery coating platforms for medical devices. It was a tissue bank and medical device company that designs, processes, manufactures, and markets advanced medical products. The firm’s designs focused on efficacy and safety for the patient, and functionality and ease of use for the surgeon to fulfill niche needs in the industry. The company was founded by Guy S. Cook in 1997 and is headquartered in Belgrade, MT.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

Pervasis Therapeutics, Inc. is a clinical stage company developing a broad portfolio of biologically active therapeutics. The company was founded by Robert S. Langer Jr. and Helen Marie Nugent in 2004 and is headquartered in Waltham, MA.

CorNova, Inc. develops medical devices. It product, FiberHalo SRM Stent Deployment Catheter, enables the physician to deploy a stent and measure in-stent lumen area during the angioplasty procedure. The company was founded by S. Eric Ryan in 2003 and is headquartered in Burlington, MA.

Monitor is an American private investment company.

Aton Pharma, Inc. develops therapeutics for cancer and other diseases. Its products include Edecrin, Sodium Edecrin, Cuprimine, Demser and Syprine. The company was founded by Michael G. Wells in 2001 and is headquartered in Lawrenceville, NJ.

Taiho Pharmaceutical Co., Ltd. engages in the production of drugs and medical products. It researches, innovates, and develops pharmaceuticals for various diseases. The company was founded on June 1, 1963 and is headquartered in Tokyo, Japan.

FMR LLC engages in the provision of financial and investment services. It offers financial planning and advice, wealth management, retirement plans, trading and brokerage services, and investment products. The company was founded by Edward C. Johnson II in 1946 and is headquartered in Boston, MA.

Part of WebMD Health Corp., Complete Healthcare Communications, Inc. specializes in publication planning. The company is based in Chadds Ford, PA. The company was founded by Robert Norris. Robert Norris has been the CEO since incorporation. Complete Healthcare Communications was acquired by MediMedia USA, Inc. on April 05, 2007.

DFW Real Estate Group, Inc. provides real estate brokerage services. It provides its services through the following companies DFW Real Estate, DFW Funding Solutions, DFW Relo Solutions, DFW Corporate Housing Solutions, Acquisition Management Group (AMG), Stewart Title, Coppermark Bank, and CNR Insurance Brokerage Services. The company was founded in 1997 and is headquartered in Dallas, TX.

NeuroHealing Pharmaceuticals, Inc. develops drug therapies for the post-acute and chronic neuro-rehabilitation patients. Its products include NH001, a dopaminergic agent to help post traumatic brain injury patients to emerge from a coma, vegetative, or minimally consciousness state, NH004, a treatment for the social debilitating condition of sialorrhea, a non-motor complaint of Parkinson's disease patients and NH02D, an orally administered drug for on-demand treatment of premature ejaculation, a male sexual disorder affecting sexually active men. The company was founded by Esteban Fridman and Daniel Katzman in 2003 and is headquartered in Waban, MA.

Locust Walk Partners LLC provides commercial supporting and advisory services. The firm involves in securities-related transactions for clients, including mergers and acquisitions, private placements & mezzanine financings and partnerships involving equity investments. The company was founded by Geoff Meyerson and Joseph Mohr in 2008 and is headquartered in Boston, MA.

Zevacor Pharma, Inc. develops molecular imaging solutions. It also manufactures and distributes radiopharmaceutical products. The company was founded in 1986 and is headquartered in Noblesville, IN.

Jubilant Pharma Ltd. manufactures pharmaceutical products. Its products include solid dosage formulations, radiopharmaceuticals and allergy therapy products. The firm provides contract manufacturing services. The company is headquartered in Singapore.

Part of Aseko, Inc., Glytec LLC is a healthcare provider company that specializes in improving the quality and cost of care for diabetes patients. The company, founded in 2006 by Robby Booth, is based in Waltham, MA, and has Edmond L. Furlong as its CEO since 2018. Glytec's FDA-cleared titration software and proprietary algorithms deliver personalized diabetes treatment recommendations across the continuum of care, from hospital to home. The company's eGlycemic Management System (eGMS) is an EHR-integrated cloud-based software solution that supports safe and effective glycemic management and insulin dosing. Glytec supports the transition from sliding scale to basal bolus insulin for standardization of insulin therapy across critical and non-critical care settings. The safety and efficacy of Glytec's solutions have been validated by several dozen studies published in medical journals and presented at scientific conferences.

Jubilant Pharma Holdings, Inc. operates as a pharmaceutical company. The private company is based in Bedminster, NJ.

LIPAC Oncology LLC engages in the provision of drug delivery services. It offers LiPax, a proliposomal intracavitary paclitaxel drug delivery platform. The company was founded by Ramachandran R. Thirucote, Willem A. Robberts and Michael Oefelein in 2016 and is headquartered in Pomona, CA.